Preclinical neuroscience company
FundaMental Pharma has raised €10M across 1 funding round from 3 investors, most recently a Seed round in Nov 2022. Based in Heidelberg, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-21 | Seed | €10M |
| BioGeneration Ventures,High Tech Gründerfonds,Thuja Capital |
| View deal → |
